{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:12:22Z","timestamp":1749096742175,"version":"3.41.0"},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med. Technol."],"accepted":{"date-parts":[[2025,3,20]]},"published-print":{"date-parts":[[2025,6]]},"DOI":"10.2967\/jnmt.124.269395","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T15:05:15Z","timestamp":1745334315000},"page":"140-145","source":"Crossref","is-referenced-by-count":0,"title":["Single- Versus Dual-Time-Point Imaging for Transthyretin Cardiac Amyloid Using<sup>99m<\/sup>Tc-Pyrophosphate"],"prefix":"10.2967","volume":"53","author":[{"given":"Wesley","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunthi","family":"Pathmaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Kovaleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kench","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raef","family":"Boktor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1602","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"2025060405400882000_53.2.140.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01274-X"},{"key":"2025060405400882000_53.2.140.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.123.265492"},{"key":"2025060405400882000_53.2.140.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.10.049"},{"key":"2025060405400882000_53.2.140.4","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehx043","article-title":"Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths","volume":"38","author":"Gonz\u00e1lez-L\u00f3pez","year":"2017","journal-title":"Eur Heart J."},{"key":"2025060405400882000_53.2.140.5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jjcc.2019.05.011","article-title":"Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy","volume":"75","author":"Ochi","year":"2020","journal-title":"J Cardiol."},{"key":"2025060405400882000_53.2.140.6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jjcc.2020.06.019","article-title":"Validation of the Kumamoto criteria for prediction of 99mtechnetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: a retrospective cohort study in Kochi","volume":"77","author":"Ochi","year":"2021","journal-title":"J Cardiol."},{"key":"2025060405400882000_53.2.140.7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.semnuclmed.2020.01.001","article-title":"Multimodality imaging in the evaluation and management of cardiac amyloidosis","volume":"50","author":"Khor","year":"2020","journal-title":"Semin Nucl Med."},{"key":"2025060405400882000_53.2.140.8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12350-016-0610-4","article-title":"Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis","volume":"25","author":"Bokhari","year":"2018","journal-title":"J Nucl Cardiol."},{"key":"2025060405400882000_53.2.140.9","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s12350-022-03180-5","article-title":"Diagnostic value of heart-to-mediastinum ratio in 99mTc-pyrophospate SPECT\/CT for transthyretin cardiac amyloidosis","volume":"30","author":"Ikoma","year":"2023","journal-title":"J Nucl Cardiol."},{"key":"2025060405400882000_53.2.140.10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1253\/circrep.CR-19-0015","article-title":"Utility of 99 mTc-pyrophosphate scintigraphy in diagnosing transthyretin cardiac amyloidosis in real-world practice","volume":"1","author":"Tsutsui","year":"2019","journal-title":"Circ Rep."},{"key":"2025060405400882000_53.2.140.11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0001-2998(80)80029-8","article-title":"Pathophysiologic considerations and clinicopathological correlates of technetium-99m stannous pyrophosphate myocardial scintigraphy","volume":"10","author":"Willerson","year":"1980","journal-title":"Semin Nucl Med."},{"key":"2025060405400882000_53.2.140.12","unstructured":"ASNC Practice Points. 99mTechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. American Society of Nuclear Cardiology website. https:\/\/www.asnc.org\/wp-content\/uploads\/2024\/05\/19110-2021-ASNC-Amyloid-Practice-Points-PYP-MAY19-2022-1.pdf. Updated May 19, 2022. Accessed April 3, 2025."},{"key":"2025060405400882000_53.2.140.13","unstructured":"ASNC and EANM Cardiac Amyloidosis Practice Points. 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) and 99mTechnetium-hydroxymethylene diphosphonate (HMDP) imaging for transthyretin cardiac amyloidosis. American Society of Nuclear Cardiology website. https:\/\/www.asnc.org\/wp-content\/uploads\/2024\/05\/19110-ASNC-AND-EANM-Amyloidosis-Practice-Points-WEB2-2.pdf. Published September 2019. Accessed April 3, 2025."},{"key":"2025060405400882000_53.2.140.14","unstructured":"ASNC Amyloid Reporting Template. Interpretation and reporting of cardiac scintigraphy with bone-avid tracers in suspected transthyretin cardiac amyloidosis (ATTR-CA). American Society of Nuclear Cardiology website. https:\/\/www.asnc.org\/wp-content\/uploads\/2024\/07\/Interpretation-and-Reporting-Template-Booklet-DIGITAL.pdf. Updated July 2024. Accessed April 3, 2025."},{"key":"2025060405400882000_53.2.140.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.03.020"},{"key":"2025060405400882000_53.2.140.16","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2025060405400882000_53.2.140.17","doi-asserted-by":"crossref","first-page":"e024717","DOI":"10.1161\/JAHA.121.024717","article-title":"Correlation between cardiac images, biomarkers, and amyloid load in wild-type transthyretin amyloid cardiomyopathy","volume":"11","author":"Morioka","year":"2022","journal-title":"J Am Heart Assoc."},{"key":"2025060405400882000_53.2.140.18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1253\/circj.CJ-22-0118","article-title":"Extracardiac biopsy sensitivity in transthyretin amyloidosis cardiomyopathy patients with positive 99mTc-labeled pyrophosphate scintigraphy findings","volume":"86","author":"Nishi","year":"2022","journal-title":"Circ J."},{"key":"2025060405400882000_53.2.140.19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11604-021-01221-6","article-title":"Usefulness of quantitative 99mTc-pyrophosphate SPECT\/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis","volume":"40","author":"Ogasawara","year":"2022","journal-title":"Jpn J Radiol."},{"key":"2025060405400882000_53.2.140.20","doi-asserted-by":"crossref","first-page":"e010249","DOI":"10.1161\/CIRCIMAGING.119.010249","article-title":"Efficient 1-hour technetium-99m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis","volume":"13","author":"Masri","year":"2020","journal-title":"Circ Cardiovasc Imaging."},{"key":"2025060405400882000_53.2.140.21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol."},{"key":"2025060405400882000_53.2.140.22","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s12350-021-02715-6","article-title":"An optimized imaging protocol for [99mTc]Tc-DPD scintigraphy and SPECT\/CT quantification in cardiac transthyretin (ATTR) amyloidosis","volume":"28","author":"Schatka","year":"2021","journal-title":"J Nucl Cardiol."},{"key":"2025060405400882000_53.2.140.23","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s12350-020-02273-3","article-title":"Tc-99m-PYP imaging for cardiac amyloidosis: defining the best protocol before the flood gates burst","volume":"27","author":"Bokhari","year":"2020","journal-title":"J Nucl Cardiol."},{"key":"2025060405400882000_53.2.140.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.123.265415"},{"key":"2025060405400882000_53.2.140.25","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro","year":"2018","journal-title":"Clin Med (Lond)."},{"key":"2025060405400882000_53.2.140.26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/10815589241261279","article-title":"Epidemiology, diagnosis, and management of cardiac amyloidosis","volume":"72","author":"Bashir","year":"2024","journal-title":"J Investig Med."},{"key":"2025060405400882000_53.2.140.27","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1988.00380030168027"}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.124.269395","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T12:40:51Z","timestamp":1749040851000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.124.269395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,4]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.2967\/jnmt.124.269395"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.124.269395","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"type":"print","value":"0091-4916"},{"type":"electronic","value":"1535-5675"}],"subject":[],"published":{"date-parts":[[2025,4,22]]}}}